Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.9 Billion USD | -10.34% |
| 2022 | 15.51 Billion USD | -20.06% |
| 2021 | 19.4 Billion USD | -6.53% |
| 2020 | 20.75 Billion USD | 27.2% |
| 2019 | 16.32 Billion USD | 28.1% |
| 2018 | 12.73 Billion USD | 9.43% |
| 2017 | 11.64 Billion USD | 31.8% |
| 2016 | 8.83 Billion USD | 10.32% |
| 2015 | 8 Billion USD | 5.27% |
| 2014 | 7.6 Billion USD | 1.26% |
| 2013 | 7.51 Billion USD | 14.99% |
| 2012 | 6.53 Billion USD | 12.28% |
| 2011 | 5.81 Billion USD | 11.77% |
| 2010 | 5.2 Billion USD | 18.52% |
| 2009 | 4.39 Billion USD | 23.45% |
| 2008 | 3.55 Billion USD | 19.3% |
| 2007 | 2.98 Billion USD | 54.18% |
| 2006 | 1.93 Billion USD | 92.44% |
| 2005 | 1 Billion USD | 7.22% |
| 2004 | 937.51 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 14.82 Billion USD | -3.42% |
| 2023 Q1 | 14.68 Billion EUR | 1.31% |
| 2023 FY | 13.9 Billion EUR | -4.05% |
| 2023 Q3 | 13.9 Billion EUR | -5.29% |
| 2023 Q2 | 16.01 Billion USD | 3.25% |
| 2023 Q4 | 15.35 Billion USD | -4.16% |
| 2022 Q2 | 20.73 Billion USD | -3.93% |
| 2022 FY | 14.49 Billion EUR | -23.65% |
| 2022 Q4 | 15.51 Billion USD | -25.17% |
| 2022 Q1 | 19.78 Billion EUR | 4.19% |
| 2022 Q3 | 14.49 Billion EUR | -26.72% |
| 2021 Q2 | 21.04 Billion USD | 1.38% |
| 2021 Q4 | 21.57 Billion USD | 2.53% |
| 2021 Q3 | 17.07 Billion EUR | -3.8% |
| 2021 FY | 18.98 Billion EUR | 11.89% |
| 2021 Q1 | 17.74 Billion EUR | 4.6% |
| 2020 Q4 | 20.75 Billion USD | 19.56% |
| 2020 FY | 16.96 Billion EUR | 16.7% |
| 2020 Q1 | 15.45 Billion EUR | 6.33% |
| 2020 Q2 | 17.36 Billion USD | 6.39% |
| 2020 Q3 | 16.96 Billion EUR | 9.75% |
| 2019 Q1 | 14.32 Billion EUR | 28.5% |
| 2019 Q2 | 16.3 Billion USD | 28.01% |
| 2019 FY | 14.53 Billion EUR | 30.46% |
| 2019 Q3 | 14.53 Billion EUR | 1.52% |
| 2019 Q4 | 16.32 Billion USD | 0.07% |
| 2018 Q2 | 12.18 Billion USD | 4.64% |
| 2018 Q3 | 11.14 Billion EUR | 6.81% |
| 2018 Q1 | 10.43 Billion EUR | 7.62% |
| 2018 FY | 11.14 Billion EUR | 14.95% |
| 2018 Q4 | 12.73 Billion USD | 4.58% |
| 2017 Q4 | 11.64 Billion USD | 11.42% |
| 2017 Q1 | 9.16 Billion EUR | 10.04% |
| 2017 FY | 9.69 Billion EUR | 16.45% |
| 2017 Q2 | 10.44 Billion USD | 19.0% |
| 2017 Q3 | 9.69 Billion EUR | 5.82% |
| 2016 Q3 | 8.37 Billion EUR | 7.21% |
| 2016 Q4 | 8.78 Billion USD | 12.41% |
| 2016 Q2 | 7.81 Billion EUR | 0.0% |
| 2016 FY | 8.32 Billion EUR | 12.95% |
| 2016 Q1 | 7.81 Billion EUR | 5.98% |
| 2015 Q1 | 6.75 Billion EUR | 7.43% |
| 2015 Q2 | 6.75 Billion EUR | 0.0% |
| 2015 Q3 | 7.37 Billion EUR | 9.15% |
| 2015 FY | 7.37 Billion EUR | 17.26% |
| 2015 Q4 | 7.37 Billion EUR | 0.0% |
| 2014 Q1 | 5.85 Billion EUR | 7.34% |
| 2014 FY | 6.28 Billion EUR | 15.31% |
| 2014 Q4 | 6.28 Billion EUR | 0.0% |
| 2014 Q3 | 6.28 Billion EUR | 7.43% |
| 2014 Q2 | 5.85 Billion EUR | 0.0% |
| 2013 Q1 | 5.06 Billion EUR | 2.26% |
| 2013 Q3 | 5.45 Billion EUR | 7.59% |
| 2013 Q4 | 5.45 Billion EUR | 0.0% |
| 2013 FY | 5.45 Billion EUR | 10.02% |
| 2013 Q2 | 5.06 Billion EUR | 0.0% |
| 2012 Q4 | 4.95 Billion EUR | 0.0% |
| 2012 FY | 4.95 Billion EUR | 10.56% |
| 2012 Q2 | 4.57 Billion EUR | 0.0% |
| 2011 FY | 4.48 Billion EUR | 15.51% |
| 2011 Q4 | 4.48 Billion EUR | 0.0% |
| 2011 Q2 | 4 Billion EUR | 0.0% |
| 2010 Q4 | 3.88 Billion EUR | 0.0% |
| 2010 FY | 3.88 Billion EUR | 26.75% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 Q2 | 2.71 Billion EUR | 0.0% |
| 2009 FY | 3.06 Billion EUR | 19.03% |
| 2009 Q4 | 3.06 Billion EUR | 0.0% |
| 2008 FY | 2.57 Billion EUR | 26.09% |
| 2007 FY | 2.03 Billion EUR | 74.77% |
| 2006 FY | 1.16 Billion EUR | 36.67% |
| 2005 FY | 853.95 Million EUR | 23.81% |
| 2004 FY | 689.73 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| The Amacore Group, Inc. | 12.04 Million USD | -115359.34% |
| Arem Pacific Corporation | 259.81 Thousand USD | -5353022.077% |
| Assisted 4 Living, Inc. | 264.81 Thousand USD | -5251967.52% |
| BioCorRx Inc. | 388.88 Thousand USD | -3576260.228% |
| Bionik Laboratories Corp. | 3.36 Million USD | -413566.706% |
| Banyan Corp. | 4.5 Million USD | -308765.904% |
| Clearday, Inc. | 33.75 Million USD | -41108.256% |
| Dental Patient Care America, Inc. | 2.24 Million USD | -619748.799% |
| Quantum Medical Transport, Inc. | 1298.56 USD | -1071032428.339% |
| Empower Clinics Inc. | 2.96 Million USD | -469277.093% |
| First Choice Healthcare Solutions, Inc. | 3.12 Million USD | -445207.937% |
| Selectis Health, Inc. | 40.67 Million USD | -34095.974% |
| Ethema Health Corporation | 11.51 Million USD | -120637.803% |
| HealthLynked Corp. | 4.28 Million USD | -324842.642% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 93.12 Million USD | -14834.07% |
| JRSIS Health Care Corporation | 2.14 Million USD | -648435.223% |
| Comjoyful International Company | 1.21 Million USD | -1141785.984% |
| Medical Facilities Corporation | 353.06 Million USD | -3839.17% |
| MedSmart Group Inc. | 751.69 Thousand USD | -1850111.122% |
| North America Frac Sand, Inc. | 356.16 Thousand USD | -3904798.812% |
| Nova Leap Health Corp. | 20.89 Million USD | -66459.063% |
| Nexteligent Holdings, Inc. | 446.95 Thousand USD | -3111622.657% |
| PAO Group, Inc. | 575.00 USD | -2418782508.696% |
| Primemd Inc. | 15.32 Million USD | -90659.729% |
| Raffles Medical Group Ltd | 1.15 Billion USD | -1100.986% |
| Ryman Healthcare Limited | 7.82 Billion USD | -77.844% |
| Stem Cell Authority, Ltd. | 15.00 USD | -92719999900.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 7.22 Million USD | -192417.029% |
| Mycotopia Therapies, Inc. | 2.21 Million USD | -626552.182% |
| U.S. NeuroSurgical Holdings, Inc. | 1.32 Million USD | -1052738.759% |
| Veltex Corporation | 1.8 Million USD | -771225.417% |
| World Financial Holding Group | 292.00 USD | -4763013598.63% |
| Xcelerate Inc. | 1.91 Million USD | -724666.449% |